文献速递间质性肺疾病睡眠呼吸障碍

夜间低氧血症与进展性纤维化间质性肺病症状进展及死亡相关

Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease.
PubMed 文献 · Chest · 2023-05-13

前瞻性观察队列研究纳入102例无日间低氧血症的纤维化间质性肺病患者,基线行家庭睡眠监测并随访至少1年或至死亡。19.6%存在 prolonged NH,31.4%存在OSA;NH与生活质量更快下降及1年全因死亡率升高相关,OSA无此关联,肺功能年化变化无显著差异。

要点

  • 无日间低氧血症的F-ILD患者中,约两成存在 prolonged NH,三成存在OSA。
  • prolonged NH与1年全因死亡率升高相关(HR 8.21,95%CI 2.40-28.1)。
  • NH与生活质量更快下降相关,但肺功能年化变化无显著差异。

核心结论

  • prolonged NH而非OSA,与F-ILD患者疾病相关生活质量恶化和死亡率增加相关。

研究设计与样本

  • 前瞻性观察队列研究,纳入102例无日间低氧血症的F-ILD患者,基线行家庭睡眠监测,随访至少1年或至死亡。

主要发现

  • 102例中20例(19.6%)存在 prolonged NH,32例(31.4%)存在OSA。
  • NH组K-BILD问卷变化为-11.3 ± 5.3分,无NH组为-6.7 ± 6.5分,P = .005。
  • NH组1年全因死亡率更高,风险比8.21(95%CI 2.40-28.1,P < .001)。
  • 肺功能年化变化在组间无统计学显著差异。

关键数值与推荐

  • prolonged NH定义为睡眠中血氧饱和度<90%的时间占比≥10%。
  • OSA定义为呼吸暂停低通气指数≥15次/小时。

临床怎么用

  • 对无日间低氧血症的F-ILD患者,可考虑家庭睡眠监测识别 prolonged NH。
  • 识别 prolonged NH有助于判断生活质量恶化与死亡风险较高的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: OSA and nocturnal hypoxemia (NH) are common in patients with fibrotic interstitial lung disease (F-ILD), but their relationship with disease outcomes remains unclear. RESEARCH QUESTION: What is the relationship between NH and OSA and clinical outcomes in patients with F-ILD? STUDY DESIGN AND METHODS: This was a prospective observational cohort study of patients with F-ILD and without daytime hypoxemia. Patients underwent home sleep study at baseline and were followed up for at least 1 year or until death. NH was defined as ≥ 10% of sleep with oxygen saturation of < 90%. OSA was defined as an apnea-hypopnea index of ≥ 15 events/h. RESULTS: Among 102 participants (male, 74.5%; age, 73.0 ± 8.7 years; FVC, 2.74 ± 0.78 L; 91.1% idiopathic pulmonary fibrosis), 20 patients (19.6%) demonstrated prolonged NH and 32 patients (31.4%) showed OSA. No significant differences were found between those with and without NH or OSA at baseline. Despite this, NH was associated with a more rapid decline in both quality of life as measured by the King's Brief Interstitial Lung Disease questionnaire (change, -11.3 ± 5.3 points in the NH group vs -6.7 ± 6.5 in those without NH; P = .005) and higher all-cause mortality at 1 year (hazard ratio, 8.21; 95% CI, 2.40-28.1; P < .001). No statistically significant difference was seen between the groups in annualized change in measures of pulmonary function testing. INTERPRETATION: Prolonged NH, but not OSA, is associated with worsening disease-related quality of life and increased mortality in patients with F-ILD.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Myall KJ, West AG, Martinovic JL, et al. Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease. Chest. 2023. PMID: 37187434. doi:10.1016/j.chest.2023.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。